You are here
Regulatory framework for personalised medical devices: Frequently asked questions
Updated 24 August to reflect recent regulatory changes
The Therapeutic Goods Administration (TGA) has compiled these frequently asked questions to provide further clarity on the regulatory framework for personalised medical devices. This document should be read in conjunction with the guidance document Personalised medical devices (including 3D-printed devices): Regulatory changes for custom-made medical devices.
It is important that you read both the guidance document and the frequently asked questions before contacting the TGA with further enquiries.
The definition of a medical device as set out in section 41BD of the Therapeutic Goods Act 1989 (the Act) as follows.
(1) A medical device is:
- (a) any instrument, apparatus, appliance, software, implant, reagent, material or other article (whether used alone or in combination, and including the software necessary for its proper application) intended, by the person under whose name it is or is to be supplied, to be used for human beings for the purpose of one or more of the following:
and that does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but that may be assisted in its function by such means; or
- (i) diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of disease;
- (ii) diagnosis, monitoring, treatment, alleviation of or compensation for an injury or disability;
- (iii) investigation, replacement or modification of the anatomy or of a physiological or pathological process or state;
- (iv) control or support of conception;
- (v) in vitro examination of a specimen derived from the human body for a specific medical purpose;
- (aa) any instrument, apparatus, appliance, software, implant, reagent, material or other article specified under subsection (2A); or
- (ab) any instrument, apparatus, appliance, software, implant, reagent, material or other article that is included in a class of instruments, apparatus, appliances, software, implants, reagents, materials or other articles specified under subsection (2B); or
- (b) an accessory to an instrument, apparatus, appliance, software, implant, reagent, material or other article covered by paragraph (a), (aa) or (ab); or
- (c) a system or procedure pack.
Note: Declarations under subsection (3) exclude articles from the scope of this definition. Declarations under section 7 can also have this effect: see subsection 7(4).
If a product you manufacture, import or supply meets the definition of a medical device, you are regulated by the TGA and have obligations that you will need to meet.
The information in this document specifically pertains to personalised medical devices.
Personalised medical devices are medical devices that are devices that are specifically designed and manufactured, or adapted/modified, to meet the needs of an individual. The TGA uses three (3) specific terms to describe personalised medical devices:
- Patient-matched medical devices;
- Adaptable medical devices; and
- Custom-made medical devices
Both patient-matched and custom-made medical devices are personalised before they are manufactured. Dental aligners, for example, are a patient-matched medical device that are designed in a software suite to suit a specific person before they are manufactured.
Adaptable medical devices are personalised after they are manufactured. A limb prosthesis, for example, is assembled using pre-manufactured components to meet the needs of a specific person.
It is important to understand what these definitions mean. Please refer to Personalised medical devices (including 3D-printed devices): Regulatory changes for custom-made medical devices for more information.
The definition of a manufacturer of a medical device can be found in section 41BG of the Act. You are strongly encouraged to read the definition to ensure you understand whether or not you are a manufacturer of a medical device.
Generally, the legal manufacturer is the person or entity who:
- Takes responsibility for ensuring that a device is safe and fit for its intended purpose; and
- Supplies the device as a medical device under their name.
This can include parties who:
- Produce medical devices themselves;
- Outsource production of medical devices to other parties; or
- Assemble, refurbish, package, labels or assign the intended purpose to ready-made products produced by another party.
Please note: You will not meet the definition of a manufacturer if you assemble or adapt an already-supplied medical device to suit a particular patient, providing your assembly or adaptation does not change the intended purpose of the device that was assigned by the original manufacturer.
The definition of a sponsor as set out in Chapter 1, Section 3 of the Act is as follows:
sponsor, in relation to therapeutic goods, means:
- (a) a person who exports, or arranges the exportation of, the goods from Australia; or
- (b) a person who imports, or arranges the importation of, the goods into Australia; or
- (c) a person who, in Australia, manufactures the goods, or arranges for another person to manufacture the goods, for supply (whether in Australia or elsewhere);
but does not include a person who:
- (d) exports, imports or manufactures the goods; or
- (e) arranges the exportation, importation or manufacture of the goods;
on behalf of another person who, at the time of the exportation, importation, manufacture or arrangements, is a resident of, or is carrying on business in, Australia.
In short, the sponsor is the Australian-based legal entity who is responsible for ensuring that a device is legally imported into, exported from or manufactured and supplied within Australia. This includes healthcare practitioners who manufacture a medical device as a part of their clinical practice.
In most cases, an Australian manufacturer will also be the sponsor of their devices as they will be the first point of supply within Australia.
Devices imported from overseas must have an Australian-based sponsor. If you procure devices directly from an overseas manufacturer, then you meet the definition of a sponsor.
Sponsors are required to meet regulatory obligations associated with the supply of a medical device both before and after the device is imported and/or supplied including:
- Ensuring the device is included in the ARTG;
- Reporting adverse events associated with the device to the TGA; and
- Meeting advertising requirements.
A full list of the ongoing responsibilities for a medical device sponsor is available on the TGA website .
Custom-made medical devices
No. Patient-matched devices are also designed and manufactured for individual patients. A custom-made medical device is a device that is made using manufacturing methods that cannot be validated, verified or reproduced, and which is produced only in rare circumstances where no other suitable patient-matched alternatives are available. If you are making a kind of device many times over using similar materials and methods, it is likely your device will meet the definition of 'patient-matched' and will require inclusion in the ARTG.
No. Many mass-produced medical devices are also made or finished by hand (for example, porcine heart valves). If you are making a kind of device many times over using similar materials and methods, it is likely your device will meet the definition of 'patient-matched' and will require inclusion in the ARTG, even if it is made by hand.
No. This is because the definition of a custom-made medical device is not determined by what kind of device it is.
The requirement under regulation 10.3 of the Regulations for Australian-based manufacturers and sponsors to inform the TGA that they are supplying a kind of custom-made medical device has been a requirement since 2002.
If your medical device does not meet the definition of a custom-made medical device, you must include it in the ARTG. If you are manufacturing, importing or supplying a medical device within, or exporting a medical device from, Australia without a valid inclusion in the ARTG, you may be subject to civil or criminal penalties (see section 41MI of the Act).
If you would like to discuss your specific circumstances, please contact firstname.lastname@example.org.
Patient-matched medical devices
The specified design envelope is the limits of design a manufacturer can be confident (with the support of objective evidence) will result in a medical device that is safe, and will meet the intended recipient's requirements (i.e. design validation). Factors that inform the specified design envelope could include:
- Industry standards;
- Clinical practice guidelines;
- Specialist training;
- Specifications for materials;
- Dimensions; and
Please note: objective evidence includes information given to you through tertiary study or during on-the-job training. While you may not have access to the specific clinical data that underpins the design and manufacture of the devices produced in your profession, as a professional in the field you are using an evidence-based approach to the design and manufacture of the devices you are producing.
Information about the meanings of the terms 'production validation' and 'verification' relevant to medical devices is provided in the guidance document for personalised medical devices on the TGA website. There are also other resources that may assist you including the Global Harmonisation Task Force document Quality Management Systems - Process Validation (pdf,162kb).
There is confusion around when a person is manufacturing a patient-matched medical device using a raw material and when they are using an adaptable medical device.
The product is likely to be an adaptable medical device if:
- The product meets the definition of a medical device in the form that it is supplied, and only requires
- assembly or adaptation to suit the patient at the point of care; or
- a final preparatory step is required because the intended purpose of the device means it cannot be supplied in a finished form (amalgam for a filling or bone cement, for example); and
- The manufacturer:
- has included the product you are using in the ARTG; and
- has included the product at the same classification as the device you are intending to produce; and
- has stated that the intended purpose of the product is consistent with your intentions to assemble or adapt the device.
If any of the above conditions are not met, then the product is likely a raw material that you are using to produce a patient-matched medical device. If you are unsure, you should contact the manufacturer of the product to confirm whether or not it is their intention the product be an adaptable medical device or a raw material.
On 20 August 2021, refinements were made to the personalised medical devices framework, including a legislative instrument known as the Therapeutic Goods (Medical Devices—Specified Articles) Amendment (Personalised Medical Devices) Instrument 2021 came into effect. The instrument declares some raw materials and components to be a medical device when they are intended to be used by a healthcare practitioner, or by someone who is working to instructions/directions provided by a healthcare practitioner.
If you are a healthcare practitioner, or someone who is working to instructions/directions received from a healthcare practitioner and you are using materials or components named in this instrument that have been included in the ARTG, the device you make will be exempt from inclusion in the ARTG.
You will still need to meet all other regulatory requirements for your medical device including:
- ensuring it meets all relevant Essential Principles (including supplying the devices with adequate labelling and instructions for use);
- reporting adverse events to the TGA; and
- meeting the advertising requirements for therapeutic goods under the TGA legislation including the Therapeutic Goods Advertising Code.
More information about this instrument can be found on the TGA website .
Medical Device Production Systems (MDPSs)
While the definition of an MDPS has been included in the Regulations from 25 February 2021, this will not take effect until a subsequent legislative instrument declaring an MDPS to be a medical device is in place. This subsequent legislative instrument is likely to be drafted following work currently underway with the International Medical Device Regulators Forum (IMDRF) and the TGA has established regulatory structures to appropriately assess and evaluate these systems. This work is expected to conclude in September 2022.
More information can be found in the guidance document on the TGA website. Further information and guidance about MDPSs will be made available on the personalised medical devices landing page as it is developed.
No. MDPSs are only for healthcare professionals (or other suitably qualified people) working within a healthcare facility.
No. MDPSs are only for the manufacture of a patient-matched medical device.
The ARTG inclusion process
Comprehensive guidance on the process of having a device approved by the TGA for inclusion in the ARTG can be found on the TGA website. If after reading the medical device inclusion process guidance you have any specific questions, you can contact the Medical Devices Information Unit between the hours of 8:30am-5:00pm Monday to Friday via email@example.com or by phoning 1800 141 144.
The paperwork needed depends on:
- The classification of the medical device in question; and
- The conformity assessment procedures that need to be applied.
More information about classification and conformity assessment can be found on the TGA website. Additional information and resources will be published on our website as they are produced. Resources that may assist you include:
Yes. Inclusion in the ARTG is the legal basis of supply for medical devices in Australia. ARTG inclusion can also be a requirement for eligibility to apply for tenders with healthcare facilities such as hospitals and, if the device is an implantable medical device, potential reimbursement through private health funds.
Inclusions in the ARTG are for a kind of medical device. A sponsor can supply multiple devices under the one ARTG entry if the devices are of the same kind.
Devices are considered to be of the same kind if they have the following characteristics:
- the same Sponsor;
- the same Manufacturer;
- the same Classification;
- the same Global Medical Device Nomenclature System Code (GMDN code); and
- for Class III, Class AIMD medical devices and Class 4 IVD medical devices (other than an immunohaematology reagent that is a Class 4 IVD medical device), the same unique product identifier (UPI).
For example, a sponsor can have an ARTG entry for a dental needle (Class IIa, GMDN 12740). The sponsor can supply dental needles of different lengths, widths, shapes, etc., as long as they share the same manufacturer, classification and GMDN code.
Applications for inclusions in the ARTG must be submitted by an Australian-based legal entity. Each business must decide the most appropriate entity to submit an application for inclusion in the ARTG based on their own unique structure and business model. Sponsors have regulatory obligations they must fulfil both before a device is included in the ARTG, and afterwards including:
- Ensuring the device is included in the ARTG;
- Reporting adverse events associated with the device to the TGA; and
- Meeting advertising requirements.
A full list of ongoing responsibilities once your device has been included is available on the TGA website.
If you are:
- A relevant health professional practicing within Australia; or
- Meet the definition of a medical device in their own right;
- A relevant technical professional operating in Australia, at the direction of a relevant health professional practicing within Australia; and
- You are producing a patient-matched medical device using materials that have been included in the ARTG by the person who supplied them to you; and
- The ARTG-inclusion states that the materials are for use by a member of your profession, for the purposes you are using them for; then
You are exempt from needing to include the resultant patient-matched medical devices in the ARTG. Please note that when a device is exempt from inclusion in the ARTG, it does not mean the device is exempt from TGA regulation entirely. Manufacturers and sponsors of custom-made medical devices still have regulatory obligations that they must meet under TGA legislation, including ensuring that their devices comply with the Essential Principles, and that they have applied the relevant conformity assessment procedures to their products.
The Global Medical Device Nomenclature (GMDN) is a list of generic names used to identify medical device product; including products used in the diagnosis, prevention, monitoring, treatment or alleviation of disease or injury in humans. GMDN Codes and Terms allow medical devices with similar features to be identified and are used by the TGA to assist in the:
- consistent assessment of medical devices before they are approved for supply;
- ongoing monitoring of medical devices once they are available for supply; and
- exchange of post market vigilance information between regulatory bodies.
All medical devices included in the ARTG have an associated GMDN Code and Term.
You can access the list of GMDN Codes and Terms by registering with the GMDN Agency.
There are three (3) main costs associated with regulatory approval and inclusion in the ARTG:
- Costs associated with the conformity assessment procedures (including certification) that need to be applied to your device. Please note that if:
- You are importing a medical device from a manufacturer who has obtained market authorisation for the device in a comparable overseas jurisdiction recognised by the TGA; and
- The device is not a kind of medical device that is specified in regulation 4.1 of the Regulations, you may not need to undergo (and pay for) conformity assessment certification.
- The cost of an application to the TGA for inclusion in the ARTG, which is based on the classification of the kind of medical device; and
- The annual charge associated with maintaining an inclusion in the ARTG.
Once you have determined the classification of your device and what kind of assessment you require, you can review the information about fees and charges available on the TGA website.
Please note: While the TGA can provide you with advice to help you navigate the regulatory requirements and understand your regulatory obligations, you are responsible for ensuring your device is correctly classified and meets all relevant regulatory obligations. The TGA is unable to provide definitive advice about the classification of a device outside of a formal application or investigation process.
TGA will continue to liaise with stakeholders and produce guidance and information to support stakeholders who are transitioning their devices to ARTG inclusion. You can check the personalised medical devices landing page on our website to find these resources, or you can subscribe to receive this information directly by sending an email to firstname.lastname@example.org with "SUBSCRIBE PMD" in the subject line.
The TGA has engaged with more than 100 professional bodies across the health and technology sectors to develop and provide targeted information for each sector. These resources will be made available on the personalised medical devices landing page but you may also like to contact your peak body directly for assistance. If your professional body has not been contacted by the TGA, they can request further information to support their membership by contacting PersonalisedDevices@health.gov.au.
SME assist is a dedicated service that TGA offers to help small to medium enterprises (SMEs), researchers, start-ups and those unfamiliar with regulation to understand their regulatory and legislative obligations. The SME website contains a range of resources to assist people who have not had dealings with the TGA before.
Regulatory affairs consultants offer services, including advice, on regulatory matters and can provide explicit advice about your specific devices. More information about how to find a regulatory affairs consultant is available on the TGA website.
|Version||Description of change||Author||Effective date|
|V1.0||Original publication||Devices Emerging Technology & Diagnostics Section||February 2021|
|V2.0||Updated to reflect user feedback, and to incorporate changes to the transition arrangements for patient-matched medical devices||Devices Emerging Technology & Diagnostics Section||March 2021|
|V3.0||Updated to reflect recent updates to the Regulations||Devices Emerging Technology & Diagnostics Section||July 2021|
|V4.0||Updated to reflect currency of the Framework after the close of the registration period for transitioning devices, and the publication of the Therapeutic Goods (Medical Devices—Specified Articles) Instrument 2020||Devices Emerging Technology & Diagnostics Section||August 2021|